This product is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration.
Terminalia brownii
This herb is NOT recommended during pregnancy due to potential risks to the developing fetus.
This herb is NOT recommended while breastfeeding as effects on infants are unknown.
Consult your healthcare provider before use.
East African Terminalia species used for bacterial and fungal infections, malaria, and respiratory conditions; related to well-known Terminalia species.
East African Terminalia species used for bacterial and fungal infections, malaria, and respiratory conditions; related to well-known Terminalia species. Key active compounds include tannins, ellagic acid, gallic acid.
tannins, along with ellagic acid and gallic acid, are the primary bioactive compounds in Terminalia Brownii. These compounds modulates NF-κB and COX-2 inflammatory pathways, disrupts microbial cell membranes and inhibits pathogen growth.
Antibacterial activity
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antifungal effects
Limited clinical evidence; primarily supported by traditional use and preliminary studies
Antimalarial properties
Anti-inflammatory action
Bacterial infections
Based on traditional use; clinical evidence limited
Fungal infections
Based on traditional use; clinical evidence limited
Malaria
Based on traditional use; clinical evidence limited
Respiratory conditions
Based on traditional use; clinical evidence limited
Found an error or have a correction for Terminalia Brownii?
Report an Issue →